Ask the experts

Dr. Stuart Mair

Global Vice President, Medical, Early Development

Dr. Stuart Mair has over 16 years experience of delivering exploratory clinical studies in the CRO Industry. He has delivered over 100 First-in-Human (FIH) studies and is an expert in the design and implementation of exploratory clinical trials from First-in-Human to Proof-of-Concept (POC) in patient groups with PD biomarkers. Stuart has advised clients on multiple study types from simple PK, BE and characterisation studies to complex flexible designs with multiple portions delivered under a single protocol.

Prior to joining Quotient Sciences, Dr. Mair was the Medical Director at Charles River Laboratories. He holds a MBChB (Bachelor of Medicine and Bachelor of Surgery) degree and DRCOG, DCPSA, and MFPM credentials from the University of Aberdeen in the UK.

Topics of interest

First-in-Human (FIH) studies, Proof-of-Concept (POC) studies, PK characterisation studies, BE characterisation studies

Connect on LinkedIn

Visit profile

Ask a question

If you have a question for Dr. Stuart Mair, fill out the form below.

In this video, Dr. Mair discusses ... xxxxx